NANDROLONE PHENPROPIONATE IN THE TREATMENT OF GERIATRIC PATIENTS WITH CHRONIC BRAIN DAMAGE

Journal of the American Geriatrics SocietyVolume 12, Issue 4 p. 373-378 NANDROLONE PHENPROPIONATE IN THE TREATMENT OF GERIATRIC PATIENTS WITH CHRONIC BRAIN DAMAGE L. DEAN HAMILTON M.D., L. DEAN HAMILTON M.D. Staff Psychiatrist, VA Hospital, and Clinical Instructor in Internal Medicine, University of Utah College of Medicine, Salt Lake City, Utah. Veterans Administration Hospital, Salt Lake City, UtahSearch for more papers by this authorJESSE L. BENNETT M.D., JESSE L. BENNETT M.D. Chief, Psychiatric Research, VA Hospital, and Assistant Clinical Professor, Department of Psychiatry, University of Utah College of Medicine. Veterans Administration Hospital, Salt Lake City, UtahSearch for more papers by this authorJO SILVER R.N., JO SILVER R.N. Head Nurse, Medical Infirm Unit, Psychiatric Service, VA Hospital. Veterans Administration Hospital, Salt Lake City, UtahSearch for more papers by this author L. DEAN HAMILTON M.D., L. DEAN HAMILTON M.D. Staff Psychiatrist, VA Hospital, and Clinical Instructor in Internal Medicine, University of Utah College of Medicine, Salt Lake City, Utah. Veterans Administration Hospital, Salt Lake City, UtahSearch for more papers by this authorJESSE L. BENNETT M.D., JESSE L. BENNETT M.D. Chief, Psychiatric Research, VA Hospital, and Assistant Clinical Professor, Department of Psychiatry, University of Utah College of Medicine. Veterans Administration Hospital, Salt Lake City, UtahSearch for more papers by this authorJO SILVER R.N., JO SILVER R.N. Head Nurse, Medical Infirm Unit, Psychiatric Service, VA Hospital. Veterans Administration Hospital, Salt Lake City, UtahSearch for more papers by this author First published: April 1964 https://doi.org/10.1111/j.1532-5415.1964.tb06846.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Goldfarb, A. I.: Summarization of activities for the year 1958, from the Office of the Consultant on Services for the Aged. Report to the Commissioner of New York State Department of Mental Hygiene, Albany, New York, September 1959. 2 Hock, C. W.: Medical treatment of the functionally ill geriatric patient, Geriatrics 16: 182–184 (Apr.) 1961. 3 Craig, P. E.: Management of the listless patient, J. Oklahoma M. A. 53: 414–420 (June) 1960. 4 Payne, R. W.: Androgens, Anabolism, Appetite and Ambition. Summer Symposium, Kentucky Academy of General Practice, Lexington, Kentucky, August 16, 1959. 5 Sobel, I. J.: Clinical study of nandrolone phenpropionate, Clin. Med. 7: 481 (Aug) 1960. 6 Smith, C., and Johnson, P. C.: Anabolic effect of 19-nortestosterone phenpropionate in underweight geriatric women, J. Am. Geriatrics Soc. 9: 304–311 (Apr.) 1961. 7 Shatin, L., and Freed, E.: A behavior rating scale for mental patients, J. Mental Sc. 101: 644–653 (July) 1955. 8 Brochner-Mortensen, K.; Gjorup, S., and Thaysen, J. H.: The metabolic effect of new anabolic 19-nor-steroids, Acta med. scandinav. 165: 197–205 (Oct. 28) 1959. 9 Page, C. W.: The treatment of debility. Ninth Spring Meeting, Michigan and Wayne County Academies of General Practice, Detroit, March 21, 1962. 10 Lapinsohn, L. I.: The use of delta I, 17 alpha methyl testosterone as an adjuvant in the treatment of schizophrenic reactions, Dis. Nerv. System 22: 443–448 (Aug.) 1961. 11 Lapinsohn, L. I.: Anabolic steroids in the treatment of psychiatric states, Dis. Nerv. System. 23: 226–230 (Apr.) 1962. Citing Literature Volume12, Issue4April 1964Pages 373-378 ReferencesRelatedInformation